----------------------------------------

BROTHERHOOD OF MAINTENANCE OF
WAY EMPLOYEES



CONSOLIDATED RAIL CORPORATION
"Carrier"

----------------------------------------

STATEMENT OF CLAIM





OPINION OF THE BOARD

Claimant, C. Custer, was a Trackman. As is typical with many employees who occupy like positions, Claimant was essentially a seasonal employee who would normally be furloughed for the winter until the following spring.

Claimant was recalled to duty for the 1987 production season and, as part of his return to duty physical conducted on June 11,


1987, was required to submit a urine sample. Carrier was subsequently notified by Roche Biomedical Laboratories, the company that performs all of Carrier's drug screen urinalysis work, that Claimant's specimen allegedly tested positive for cannabinoids.

In accordance with Carrier's policy on drugs, Claimant was medically disqualified from service by letter dated June 17, 1987 from Carrier's Medical Director. Claimant was instructed therein to rid his system of cannabinoids and other prohibited drugs and to provide a negative urine sample within 45 days, which was by August 1, 1987, and that his failure to comply with these instructions may subject him to dismissal. In addition, the Medical Director recommended in this letter that Claimant contact Carrier's employee counselor and follow any recommendations that the counselor might make on Claimant's behalf. The Medical Director further advised that if Claimant entered a counselorapproved educational or treatment program, the time period for providing a negative urine sample could be extended.

Claimant did not enter the Carrier sponsored treatment program and he did not produce a negative urine specimen within the prescribed 45 day limit.

By notice dated September 7, 1987, Claimant was notified to attend a hearing in connection with charges concerning his alleged failure to comply with Carrier's drug testing policy. Following the hearing, Claimant was notified by Notice of Discipline dated October 7, 1987 of his dismissal in all




capacities for failing to comply with Carrier's drug testing policy.

Carrier's drug testing policy, insofar as it is applicable to this case and all cases now before this Board, was unilaterally established and set forth in a letter from Carrier's Chairman and Chief Executive officer to employees dated February 20, 1987. Carrier's Chairman stated therein that "safety is inconsistent with the use of illegal drugs by any employee, because such use endangers the welfare and safety of other employees and the public. Accordingly, Conrail is establishing a policy on drugs which is an enhancement of our current medical practice and standards. A summary of that policy is included with this letter...". The referenced policy summary which was attached to the letter stated the following:

















        date of the letter notifying the employee of his/her being withheld from service.


    An employee whose first test is positive will be offered the opportunity for an evaluation by Conrail's Employee Counseling Service.


        If the evaluation reveals no addiction problem, in order to be returned to service a negative drug test must be provided within a 45-day period beginning with~the date of the letter notifying the employee of his/her being withheld from service.


        If the evaluation indicates an addiction problem and the employe enters an approved treatment program, the employe will be returned to service upon recommendation of the treatment program and the Conrail Employee Counseling Service and must provide a negative drug test within 125 days of the date of the initial positive test. This time period can be extended by Health Services when warranted.


        An employee who fails to comply with the recommended treatment plan will be required to provide a negative drug test within the 45-day or 125-day time period referred to above, whichever is less, in order to be returned to service.


    An employee may be subject to dismissal if he or she:


          refuses to submit to drug testing as part of the physical examination;


        fails to provide a negative test within the 45-day or 225-day period referred to above, whichever applies: or


        fails to provide negative drug tests in a three year follow-up period arranged and monitored by Health Services.


This policy applies to agreement and non-agreement employees subject to required physical examinations. The Carrier maintains that Claimant was properly dismissed pursuant to this drug testing policy. It argues that Claimant

                          4

                                            35-4(0 is


was aware of the policy, did not provide a negative sample within 45 days as required by the policy and ordered by Carrier; and that Claimant was therefore guilty of insubordination. The Carrier further argues that its right to dismiss Claimant in such circumstances is not restricted by law, rule or the parties' Collective Bargaining Agreement and has in fact been endorsed by every tribunal which has heard similar cases involving Carrier, including Public Law Board 3514, which is comprised of the same Carrier and organization as this Board.

The Organization raises an extraordinary number of arguments and defenses on behalf of Claimant. In general, the Organization does not unequivocally oppose drug testing, but rather Carrier's unilateral implementation of a drug testing program. More specifically, the Organization contends that Claimant's dismissal was violative of the law and parties' Collective Bargaining Agreement. It further argues that there exist specific irregularities in carrier's handling of this case which must result in sustaining of the claim.

In Award No. 1 this Board set forth guidelines concerning how it would consider certain cases arising under Carrier's drug testing policy. Applying those principles to the facts of this case, the Board finds that the claim must be denied.

Pursuant to Carrier's policy, Claimant was given a return to work physical which included a drug screen. The testing procedures used were adequate. Carrier has established that the test result accurately showed that Claimant had cannabinoids


                          5

                                              35-~ft~t5


i.

    within his system, and that the presence of these substances was as a result of use by Claimant rather than any other reason. Claimant did not, as required by the drug testing policy, provide a negative sample within 45 days or refer to the employee counselor. Finally, there are no irregularities or other mitigating factors particular to this case which can be found to warrant sustaining of the claim. Accordingly, notwithstanding the extraordinary representation provided the Claimant by the organization, the claim must be denied.


    WARD


        Claim denied.


    F. D ZALSKI J. DODD

    Car er Memb O V anization Member


                    S. E. BUCHHEIT

                    Neutral Member


6